Compare AbCellera Biologics Inc (ABCL) vs Bank of New York Mellon Corp (BNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Bank of New York Mellon Corp — how do they compare? AbCellera Biologics Inc trades at $8.99 (market cap $2.99B), while Bank of New York Mellon Corp trades at $159.91 (market cap $108.78B). The key difference: Bank of New York Mellon Corp is far larger — about 36.4× AbCellera Biologics Inc's market cap, and Bank of New York Mellon Corp pays a 1.38% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | BNY | |
|---|---|---|
Market Cap | $2.99B | $108.78B |
Sector | Health | Financials |
52-Week High | $9.76 | $162.35 |
52-Week Low | $2.78 | $101.00 |
Enterprise Value | $2.58B | — |
Dividend Yield | — | 1.38% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Bank of New York Mellon Corp
BNY Mellon is a global investment company involved in managing and servicing financial assets throughout the investment lifecycle. The bank provides financial services for institutions, corporations, and individual investors and delivers investment management and investment services in 35 countries and more than 100 markets. BNY Mellon is the largest global custody bank in the world, with about $41.1 trillion in under custody and administration (as of Dec. 31, 2020), and can act as a single point of contact for clients looking to create, trade, hold, manage, service, distribute, or restructure investments. BNY Mellon's asset-management division manages about $2.2 trillion in assets.
Read more on BNY →
